Our team is experienced in providing service in all phases of clinical development for pharmaceutical, medical device and functional food trials. We provide a full-service concept offering the entire study team for all functions, or professionals working as a part of the customers’ study team.Read More
Crown CRO has expanded its own services offering to include Data Management and Biostatistics, with its newly implemented Data Services Function. A vital part of the clinical trials life cycle, Data services has the capability to operate on a Global level for trials of any size.Read More
A new level of customer attention, flexibility and reliability is brought to you by Crown CRO from early regulatory consulting all the way to medical device trials and CE-mark and 510(k) submissions.Read More
Crown CRO Quality Assurance Services can support you to develop, implement and update your quality systems and procedures to conform to current guidelines and regulations. We also provide auditing services to help you identify your strengths, as well as areas that need improvement.Read More
Meeting clinical study or post-marketing pharmacovigilance (PV) obligations is a key requirement for your company. If you need resources or know-how, the Crown CRO PV team can offer personalized services either to strengthen your own PV functions or as a full-service PV solution.Read More
Do you need high quality translations for your clinical trials, drug regulatory affairs or pharmaceutical marketing? Crown CRO Medical Translations can offer you all of those and much more. Go to our Medical Translations page for more information and contact details.Read More
Our Regulatory Affairs function supports your goals by providing a broad variety of flexible and cost-effective Regulatory Affairs services. Our main services cover clinical trial application submissions, regulatory strategies and documentation as well as regulatory procedures for pharmaceuticals and medical devices.Read More
Crown CRO supports pharma and biotech companies and other CROs with study rescue operations. A fresh point of view, new ideas or simple support and motivation can help to put the study back on track and bring it to a successful conclusion.Read More
We have performed trials in all phases of clinical development. We have played various roles in our projects from managing full-service trials and programs globally and regionally. We can also support in regional parts of the trials, as well as providing resources and ad hoc services in our countries. We also provide Study Rescue Services.
The local knowledge of our experienced team is what is behind of our success. The knowledge of local regulatory processes combined with a wide network of investigators and Key Opinion Leaders enables us to successfully complete our commitments to our customers.
We provide our professionalism, in-depth experience and service-oriented way of working to focus on delivering the high quality data on time and within budget.
Our 125+ professionals are located in our offices in Finland, Sweden, Denmark, Norway, Estonia, Latvia and Lithuania. Our operations also cover Iceland, Belarus, Belgium and Georgia. We also have a worldwide network of partners.
Crown CRO provides services in the pharmaceutical, biotechnology, functional food and medical device sectors, as well as to other contract research organizations. Our services also cover quality assurance, pharmacovigilance, regulatory, and translation services.
We have been involved in over 900 clinical studies in more than 18 countries in various therapeutic areas and in all phases of clinical development. We currently have 100 active clinical trials ongoing.
Our vast experience enables us to serve our customers in coordinating trials from early phases up to late phase and real-world studies with high quality data and on time delivery within budget.
Our mission is to deliver top quality services to our customers while providing an ideal working environment for our employees.
Stockholm, January 28th 2019 – Sigrid Therapeutics AB (Sigrid) and Crown CRO (Crown) today announced the initiation of the STAR clinical trial testing the efficacy and safety ofthe orally administered medical device, SiPore15™. The goal of this clinical trial is to demonstrate an improvement in measurements of metabolic disorder in patients with prediabetes and newly diagnosed untreated type 2 diabetes.Read more
Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for addiction, and Crown CRO, a contract research organization based in Finland, today announced Crown’s engagement to manage Adial’s Phase 3 clinical trial for AD04 for the treatment of alcohol use disorder (AUD). The FDA approved protocol for this Phase 3 clinical trial is a 24-week trial with 290 patients in 30 clinical sites in 5 European countries.
[English summary of the announcement released by the Pharmaceutical Information Centre on 25 Oct 2018]
For the fifth time in a row, the Investigator, Study Nurse and CRA (Clinical Research Associate) of the Year were nominated by Finnish clinical research professionals. In a clinical drug trial, the investigator, study nurse and CRA form a study team, each of them playing a significant role in terms of a safe and successful drug trial. This year’s winners were nominated and awarded with diplomas during the Clinical Trials Forum organized by the Pharmaceutical Information Centre in Helsinki on 25 October 2018.
We at Crown CRO are pleased to introduce to you our new CEO, Tarja Leikas. Our long-term leader Päivi Itkonen, who is also one of our founders, steps into the position of Chief Commercial Officer and continues on Crown CRO board. Read more
Time flies. This year marks the 17th anniversary of my career in the CRO business, and my 11th anniversary at Crown CRO. I started at Crown in March 2007, and in September the same year I was appointed Clinical Research Manager and Head of the Lithuanian office. Read more